BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25469245)

  • 1. Serum carcinoembryonic antigen and carbohydrate antigen 19-9 for prediction of malignancy and invasiveness in intraductal papillary mucinous neoplasms of the pancreas: A meta-analysis.
    Wang W; Zhang L; Chen L; Wei J; Sun Q; Xie Q; Zhou X; Zhou D; Huang P; Yang Q; Xie H; Zhou L; Zheng S
    Biomed Rep; 2015 Jan; 3(1):43-50. PubMed ID: 25469245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas.
    Fritz S; Hackert T; Hinz U; Hartwig W; Büchler MW; Werner J
    Br J Surg; 2011 Jan; 98(1):104-10. PubMed ID: 20949535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19-9 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas.
    Kim JR; Jang JY; Kang MJ; Park T; Lee SY; Jung W; Chang J; Shin Y; Han Y; Kim SW
    J Hepatobiliary Pancreat Sci; 2015 Sep; 22(9):699-707. PubMed ID: 26178866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbohydrate antigen 125 supplements carbohydrate antigen 19-9 for the prediction of invasive intraductal papillary mucinous neoplasms of the pancreas.
    Qian Y; Gong Y; Luo G; Liu Y; Wang R; Zou X; Deng S; Lin X; Chen Y; Wang X; Yu X; Cheng H; Liu C
    World J Surg Oncol; 2022 Sep; 20(1):310. PubMed ID: 36155113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraductal papillary mucinous neoplasms of the pancreas: performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy.
    Maire F; Voitot H; Aubert A; Palazzo L; O'Toole D; Couvelard A; Levy P; Vidaud M; Sauvanet A; Ruszniewski P; Hammel P
    Am J Gastroenterol; 2008 Nov; 103(11):2871-7. PubMed ID: 18775021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Performance of Diffusion-Weighted Imaging for Differentiating Malignant From Benign Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Systematic Review and Meta-Analysis.
    Xu F; Liang Y; Guo W; Liang Z; Li L; Xiong Y; Ye G; Zeng X
    Front Oncol; 2021; 11():637681. PubMed ID: 34290974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The value of preoperative CA19-9 combined with platelet-to-lymphocyte ratio in predicting invasive malignancy in intraductal papillary mucinous neoplasms].
    Li JA; Han X; Fang Y; Zhang L; Lou WH; Xu XF; Wu WC; Kuang TT; Wang DS; Rong YF
    Zhonghua Wai Ke Za Zhi; 2019 Mar; 57(3):170-175. PubMed ID: 30861644
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyst carcinoembryonic antigen in differentiating pancreatic cysts: a meta-analysis.
    Ngamruengphong S; Bartel MJ; Raimondo M
    Dig Liver Dis; 2013 Nov; 45(11):920-6. PubMed ID: 23790480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracystic Glucose Levels Appear Useful for Diagnosis of Pancreatic Cystic Lesions: A Systematic Review and Meta-Analysis.
    Guzmán-Calderón E; Md BM; Casellas JA; Aparicio JR
    Dig Dis Sci; 2022 Jun; 67(6):2562-2570. PubMed ID: 34009555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas.
    Hirono S; Tani M; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Yamaue H
    Ann Surg; 2012 Mar; 255(3):517-22. PubMed ID: 22301608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of 18-FDG PET/CT in Detecting Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Yamashita YI; Okabe H; Hayashi H; Imai K; Nakagawa S; Nakao Y; Yusa T; Itoyama R; Yama T; Umesaki N; Arima K; Miyata T; Chikamoto A; Baba H
    Anticancer Res; 2019 May; 39(5):2493-2499. PubMed ID: 31092444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and Prognostic Impact of Neutrophil-to-Lymphocyte Ratio for Intraductal Papillary Mucinous Neoplasms of the Pancreas With High-Grade Dysplasia and Associated Invasive Carcinoma.
    Hata T; Mizuma M; Motoi F; Ishida M; Morikawa T; Takadate T; Nakagawa K; Hayashi H; Kanno A; Masamune A; Kamei T; Furukawa T; Naitoh T; Unno M
    Pancreas; 2019 Jan; 48(1):99-106. PubMed ID: 30540681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging role of tumor markers and biochemistry in the preoperative invasive assessment of intraductal papillary mucinous neoplasm of the pancreas.
    You L; Ma L; Zhao WJ; Zhao YP; Dai MH
    Clin Chim Acta; 2016 Feb; 454():89-93. PubMed ID: 26746574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Accuracy of Serum CA19-9 in Patients with Cholangiocarcinoma: A Systematic Review and Meta-Analysis.
    Liang B; Zhong L; He Q; Wang S; Pan Z; Wang T; Zhao Y
    Med Sci Monit; 2015 Nov; 21():3555-63. PubMed ID: 26576628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoembryonic antigen level in the pancreatic juice is effective in malignancy diagnosis and prediction of future malignant transformation of intraductal papillary mucinous neoplasm of the pancreas.
    Hayakawa H; Fukasawa M; Sato T; Takano S; Kadokura M; Shindo H; Takahashi E; Hirose S; Kawakami S; Fukasawa Y; Maekawa S; Inoue T; Yamaguchi T; Nakayama Y; Kawaida H; Kono H; Mochizuki K; Kondo T; Ichikawa D; Enomoto N
    J Gastroenterol; 2019 Nov; 54(11):1029-1037. PubMed ID: 31111221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive performance of factors associated with malignancy in intraductal papillary mucinous neoplasia of the pancreas.
    Heckler M; Brieger L; Heger U; Pausch T; Tjaden C; Kaiser J; Tanaka M; Hackert T; Michalski CW
    BJS Open; 2018 Feb; 2(1):13-24. PubMed ID: 29951625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Associated With Invasive Intraductal Papillary Mucinous Carcinoma of the Pancreas.
    Hirono S; Kawai M; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yanagisawa A; Yamaue H
    JAMA Surg; 2017 Mar; 152(3):e165054. PubMed ID: 28122068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic ultrasound guided fine needle aspiration for the diagnosis of pancreatic cystic neoplasms: a meta-analysis.
    Thornton GD; McPhail MJ; Nayagam S; Hewitt MJ; Vlavianos P; Monahan KJ
    Pancreatology; 2013; 13(1):48-57. PubMed ID: 23395570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implication of serum CA125 for the prediction of malignancy in mucinous cystic neoplasms of the pancreas.
    Deng S; Fan Z; Gong Y; Cheng H; Jin K; Qian Y; Xiao Z; Liu Y; Wang R; Zheng Y; Ni Q; Yu X; Liu C; Luo G
    Exp Ther Med; 2020 Dec; 20(6):158. PubMed ID: 33093896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms.
    Kadayifci A; Atar M; Wang JL; Forcione DG; Casey BW; Pitman MB; Brugge WR
    Dig Endosc; 2017 Jan; 29(1):111-117. PubMed ID: 27514845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.